Nef enhances c-Cbl phosphorylation in HIV-infected CD4+ T lymphocytes

Virology

Volumn 336, Issue 2, 2005, Pages 219-228

  Yang, Polung ^a   Henderson, Andrew J ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Cbl; HIV 1; Nef; T cell signal transduction

Indexed keywords

CBL PROTEIN; CD28 ANTIGEN; NEF PROTEIN; PROTEIN KINASE LCK; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANTIGENS, CD28; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, NEF; HIV INFECTIONS; HIV-1; HUMANS; JURKAT CELLS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-CBL; TYROSINE; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 18844453211     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2005.03.021     Document Type: Article

References (72)

1. O. Acuto, S. Mise-Omata, G. Mangino, and F. Michel Molecular modifiers of T cell antigen receptor triggering threshold: the mechanism of CD28 costimulatory receptor Immunol. Rev. 192 2003 21 31
2. A. Adachi, H.E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M.A. Martin Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone J. Virol. 59 1986 284 291
3. C. Aiken, J. Konner, N.R. Landau, M.E. Lenburg, and D. Trono Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain Cell 76 1994 853 864
4. C.E. Andoniou, N.L. Lill, C.B. Thien, M.L. Lupher Jr., S. Ota, D.D. Bowtell, R.M. Scaife, W.Y. Langdon, and H. Band The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation Mol. Cell. Biol. 20 2000 851 867
5. C. Barat, and M.J. Tremblay Engagement of CD43 enhances human immunodeficiency virus type 1 transcriptional activity and virus production that is induced upon TCR/CD3 stimulation J. Biol. Chem. 277 2002 28714 28724
6. A.S. Baur, G. Sass, B. Laffert, D. Willbold, C. Cheng-Mayer, and B.M. Peterlin The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase Immunity 6 1997 283 291
7. I. Bell, T.M. Schaefer, R.P. Trible, A. Amedee, and T.A. Reinhart Down-modulation of the costimulatory molecule, CD28, is a conserved activity of multiple SIV Nefs and is dependent on histidine 196 of Nef Virology 283 2001 148 158
8. A.D. Blagoveshchenskaya, L. Thomas, S.F. Feliciangeli, C.H. Hung, and G. Thomas HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway Cell 111 2002 853 866
9. L. Buday, A. Khwaja, S. Sipeki, A. Farago, and J. Downward Interactions of Cbl with two adapter proteins, Grb2 and Crk, upon T cell activation J. Biol. Chem. 271 1996 6159 6163
10. B.K. Chen, R.T. Gandhi, and D. Baltimore CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef J. Virol. 70 1996 6044 6053
11. H. Cheng, J.P. Hoxie, and W.P. Parks The conserved core of human immunodeficiency virus type 1 Nef is essential for association with Lck and for enhanced viral replication in T-lymphocytes Virology 264 1999 5 15
12. K.A. Clouse, D. Powell, I. Washington, G. Poli, K. Strebel, W. Farrar, P. Barstad, J. Kovacs, A.S. Fauci, and T.M. Folks Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone J. Immunol. 142 1989 431 438
13. G.B. Cohen, R.T. Gandhi, D.M. Davis, O. Mandelboim, B.K. Chen, J.L. Strominger, and D. Baltimore The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells Immunity 10 1999 661 671
14. Y. Collette, H. Dutartre, A. Benziane, M. Ramos, R. Benarous, M. Harris, and D. Olive Physical and functional interaction of Nef with Lck. HIV-1 Nef-induced T-cell signaling defects J. Biol. Chem. 271 1996 6333 6341
15. K.L. Collins, B.K. Chen, S.A. Kalams, B.D. Walker, and D. Baltimore HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes Nature 391 1998 397 401
16. J.A. Cook, L. Albacker, A. August, and A.J. Henderson CD28-dependent HIV-1 transcription is associated with Vav, Rac, and NF-kappa B activation J. Biol. Chem. 278 2003 35812 35818
17. J.A. Donovan, R.L. Wange, W.Y. Langdon, and L.E. Samelson The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor J. Biol. Chem. 269 1994 22921 22924
18. J.A. Donovan, Y. Ota, W.Y. Langdon, and L.E. Samelson Regulation of the association of p120cbl with Grb2 in Jurkat T cells J. Biol. Chem. 271 1996 26369 26374
19. O.T. Fackler, and A.S. Baur Live and let die: Nef functions beyond HIV replication Immunity 16 2002 493 497
20. O.T. Fackler, W. Luo, M. Geyer, A.S. Alberts, and B.M. Peterlin Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions Mol. Cell 3 1999 729 739
21. O.T. Fackler, X. Lu, J.A. Frost, M. Geyer, B. Jiang, W. Luo, A. Abo, A.S. Alberts, and B.M. Peterlin p21-activated kinase 1 plays a critical role in cellular activation by Nef Mol. Cell. Biol. 20 2000 2619 2627
22. E.A. Feshchenko, W.Y. Langdon, and A.Y. Tsygankov Fyn, Yes, and Syk phosphorylation sites in c-Cbl map to the same tyrosine residues that become phosphorylated in activated T cells J. Biol. Chem. 273 1998 8323 8331
23. M. Fournel, D. Davidson, R. Weil, and A. Veillette Association of tyrosine protein kinase Zap-70 with the protooncogene product p120c-cbl in T lymphocytes J. Exp. Med. 183 1996 301 306
24. T. Fukazawa, K.A. Reedquist, T. Trub, S. Soltoff, G. Panchamoorthy, B. Druker, L. Cantley, S.E. Shoelson, and H. Band The SH3 domain-binding T cell tyrosyl phosphoprotein p120. Demonstration of its identity with the c-cbl protooncogene product and in vivo complexes with Fyn, Grb2, and phosphatidylinositol 3-kinase J. Biol. Chem. 270 1995 19141 19150
25. J.V. Garcia, and A.D. Miller Serine phosphorylation-independent downregulation of cell-surface CD4 by nef Nature 350 1991 508 511
26. R. Geleziunas, W. Xu, K. Takeda, H. Ichijo, and W.C. Greene HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell Nature 410 2001 834 838
27. M.E. Greenberg, A.J. Iafrate, and J. Skowronski The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes EMBO J. 17 1998 2777 2789
28. A.L. Greenway, D.A. McPhee, K. Allen, R. Johnstone, G. Holloway, J. Mills, A. Azad, S. Sankovich, and P. Lambert Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis J. Virol. 76 2002 2692 2702
29. A.J. Henderson, X. Zou, and K.L. Calame C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes J. Virol. 69 1995 5337 5344
30. A. Janardhan, T. Swigut, B. Hill, M.P. Myers, and J. Skowronski HIV-1 Nef binds the DOCK2-ELMO1 complex to activate rac and inhibit lymphocyte chemotaxis PLoS Biol. 2 2004 E6
31. M.M. Keane, O.M. Rivero-Lezcano, J.A. Mitchell, K.C. Robbins, and S. Lipkowitz Cloning and characterization of cbl-b: a SH3 binding protein with homology to the c-cbl proto-oncogene Oncogene 10 1995 2367 2377
32. F. Kirchhoff, M. Schindler, N. Bailer, G.H. Renkema, K. Saksela, V. Knoop, M.C. Muller-Trutwin, M.L. Santiago, F. Bibollet-Ruche, M.T. Dittmar, J.L. Heeney, B.H. Hahn, and J. Munch Nef proteins from simian immunodeficiency virus-infected chimpanzees interact with p21-activated kinase 2 and modulate cell surface expression of various human receptors J. Virol. 78 2004 6864 6874
33. A. Kotov, J. Zhou, P. Flicker, and C. Aiken Association of Nef with the human immunodeficiency virus type 1 core J. Virol. 73 1999 8824 8830
34. P.S. Lee, Y. Wang, M.G. Dominguez, Y.G. Yeung, M.A. Murphy, D.D. Bowtell, and E.R. Stanley The Cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation EMBO J. 18 1999 3616 3628
35. Q. Leng, G. Borkow, and Z. Bentwich Attenuated signaling associated with immune activation in HIV-1-infected individuals Biochem. Biophys. Res. Commun. 298 2002 464 467
36. G. Levkowitz, H. Waterman, E. Zamir, Z. Kam, S. Oved, W.Y. Langdon, L. Beguinot, B. Geiger, and Y. Yarden c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor Genes Dev. 12 1998 3663 3674
37. G. Levkowitz, H. Waterman, S.A. Ettenberg, M. Katz, A.Y. Tsygankov, I. Alroy, S. Lavi, K. Iwai, Y. Reiss, A. Ciechanover, S. Lipkowitz, and Y. Yarden Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1 Mol. Cell 4 1999 1029 1040
38. Y. Liu, A. Bishop, L. Witucki, B. Kraybill, E. Shimizu, J. Tsien, J. Ubersax, J. Blethrow, D.O. Morgan, and K.M. Shokat Structural basis for selective inhibition of Src family kinases by PP1 Chem. Biol. 6 1999 671 678
39. M.P. Loreto, D.M. Berry, and C.J. McGlade Functional cooperation between c-Cbl and Src-like adaptor protein 2 in the negative regulation of T-cell receptor signaling Mol. Cell. Biol. 22 2002 4241 4255
40. M.L. Lupher Jr., K.A. Reedquist, S. Miyake, W.Y. Langdon, and H. Band A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells J. Biol. Chem. 271 1996 24063 24068
41. M.L. Lupher Jr., N. Rao, M.J. Eck, and H. Band The Cbl protooncoprotein: a negative regulator of immune receptor signal transduction Immunol. Today 20 1999 375 382
42. A. Manninen, G.H. Renkema, and K. Saksela Synergistic activation of NFAT by HIV-1 nef and the Ras/MAPK pathway J. Biol. Chem. 275 2000 16513 16517
43. L.E. Marengere, C. Mirtsos, I. Kozieradzki, A. Veillette, T.W. Mak, and J.M. Penninger Proto-oncoprotein Vav interacts with c-Cbl in activated thymocytes and peripheral T cells J. Immunol. 159 1997 70 76
44. H.M. Miettinen, K. Matter, W. Hunziker, J.K. Rose, and I. Mellman Fc receptor endocytosis is controlled by a cytoplasmic domain determinant that actively prevents coated pit localization J. Cell Biol. 116 1992 875 888
45. Y. Miura-Shimura, L. Duan, N.L. Rao, A.L. Reddi, H. Shimura, R. Rottapel, B.J. Druker, A. Tsygankov, V. Band, and H. Band Cbl-mediated ubiquitinylation and negative regulation of Vav J. Biol. Chem. 278 2003 38495 38504
46. S. Miyake, K.P. Mullane-Robinson, N.L. Lill, P. Douillard, and H. Band Cbl-mediated negative regulation of platelet-derived growth factor receptor-dependent cell proliferation. A critical role for Cbl tyrosine kinase-binding domain J. Biol. Chem. 274 1999 16619 16628
47. M. Naramura, I.K. Jang, H. Kole, F. Huang, D. Haines, and H. Gu c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation Nat. Immunol. 4 2002 4
48. M. Ojaniemi, S.S. Martin, F. Dolfi, J.M. Olefsky, and K. Vuori The proto-oncogene product p120 (cbl) links c-Src and phosphatidylinositol 3′-kinase to the integrin signaling pathway J. Biol. Chem. 272 1997 3780 3787
49. Y. Ota, and L.E. Samelson The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase Science 276 1997 418 420
50. M.W. Pandori, N.J. Fitch, H.M. Craig, D.D. Richman, C.A. Spina, and J.C. Guatelli Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein J. Virol. 70 1996 4283 4290
51. M. Panigada, S. Porcellini, E. Barbier, S. Hoeflinger, P.A. Cazenave, H. Gu, H. Band, H. von Boehmer, and F. Grassi Constitutive endocytosis and degradation of the pre-T cell receptor J. Exp. Med. 195 2002 1585 1597
52. N. Rao, A.K. Ghosh, S. Ota, P. Zhou, A.L. Reddi, K. Hakezi, B.K. Druker, J. Wu, and H. Band The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation EMBO J. 20 2001 7085 7095
53. N. Rao, S. Miyake, A.L. Reddi, P. Douillard, A.K. Ghosh, I.L. Dodge, P. Zhou, N.D. Fernandes, and H. Band Negative regulation of Lck by Cbl ubiquitin ligase Proc. Natl. Acad. Sci. U.S.A. 99 2002 3794 3799
54. G.H. Renkema, and K. Saksela Interactions of HIV-1 NEF with cellular signal transducing proteins Front. Biosci. 5 2000 D268 D283
55. G.H. Renkema, A. Manninen, and K. Saksela Human immunodeficiency virus type 1 Nef selectively associates with a catalytically active subpopulation of p21-activated kinase 2 (PAK2) independently of PAK2 binding to Nck or beta-PIX J. Virol. 75 2001 2154 2160
56. K. Saksela, G. Cheng, and D. Baltimore Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4 EMBO J. 14 1995 484 491
57. K.V. Salojin, J. Zhang, and T.L. Delovitch TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway J. Immunol. 163 1999 844 853
58. E. Schaeffer, R. Geleziunas, and W.C. Greene Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions J. Virol. 75 2001 2993 3000
59. J.A. Schrager, and J.W. Marsh HIV-1 Nef increases T cell activation in a stimulus-dependent manner Proc. Natl. Acad. Sci. U.S.A. 96 1999 8167 8172
60. J.A. Schrager, V. Der Minassian, and J.W. Marsh HIV Nef increases T cell ERK MAP kinase activity J. Biol. Chem. 277 2002 6137 6142
61. O. Schwartz, V. Marechal, S. Le Gall, F. Lemonnier, and J.M. Heard Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein Nat. Med. 2 1996 338 342
62. D.C. Shugars, M.S. Smith, D.H. Glueck, P.V. Nantermet, F. Seillier-Moiseiwitsch, and R. Swanstrom Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo J. Virol. 67 1993 4639 4650
63. A. Simmons, V. Aluvihare, and A. McMichael Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators Immunity 14 2001 763 777
64. D.B. Straus, and A. Weiss Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor Cell 70 1992 585 593
65. T. Swigut, N. Shohdy, and J. Skowronski Mechanism for down-regulation of CD28 by Nef EMBO J. 20 2001 1593 1604
66. C.B. Thien, and W.Y. Langdon Cbl: many adaptations to regulate protein tyrosine kinases Nat. Rev., Mol. Cell Biol. 2 2001 294 307
67. F. Vilhardt, O. Plastre, M. Sawada, K. Suzuki, M. Wiznerowicz, E. Kiyokawa, D. Trono, and K.H. Krause The HIV-1 Nef protein and phagocyte NADPH oxidase activation J. Biol. Chem. 277 2002 42136 42143
68. J.K. Wang, E. Kiyokawa, E. Verdin, and D. Trono The Nef protein of HIV-1 associates with rafts and primes T cells for activation Proc. Natl. Acad. Sci. U.S.A. 97 2000 394 399
69. H.Y. Wang, Y. Altman, D. Fang, C. Elly, Y. Dai, Y. Shao, and Y.C. Liu Cbl promotes ubiquitination of the T cell receptor zeta through an adaptor function of Zap-70 J. Biol. Chem. 276 2001 26004 26011
70. D. Wolf, V. Witte, B. Laffert, K. Blume, E. Stromer, S. Trapp, P. d'Aloja, A. Schurmann, and A.S. Baur HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals Nat. Med. 7 2001 1217 1224
71. Y. Wu, and J.W. Marsh Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA Science 293 2001 1503 1506
72. X.N. Xu, B. Laffert, G.R. Screaton, M. Kraft, D. Wolf, W. Kolanus, J. Mongkolsapay, A.J. McMichael, and A.S. Baur Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain J. Exp. Med. 189 1999 1489 1496